1-3 of 3
Manfred Hensel, M.D.
Close
Sort by
Journal Articles

Quantitative Gene Expression Analysis of Surrogate Markers for Genetic Risk Groups and Survival in CLL

Dirk Kienle, Axel Benner, Dirk Winkler, Manfred Hensel, M.D., Riccardo Dalla-Favera, Peter Lichter, Stephan Stilgenbauer, MD, PhD, Hartmut Döhner
Journal: Blood
Blood (2008) 112 (11): 4170.
https://doi.org/10.1182/blood.V112.11.4170.4170
Published: 2008
Journal Articles

Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Samira Zeynalova, Eva Lengfelder, M.D., Astrid Franke, M.D., Marcel Reiser, M.D., Hjalmar Steinhauer, M.D., Michael Clemens, M.D., Christina Nickenig, M.D., Maike de Wit, M.D., Bernd Metzner, M.D., Manfred Hensel, M.D., Hans-Guenther Mergenthaler, M.D., Ruediger Liersch, M.D., Ulrich Duehrsen, M.D., Leopold Balleisen, M.D., Monika Engelhardt, M.D., Viola Poeschel, M.D., Joerg Schubert, M.D., Lorenz Truemper, M.D., Norbert Schmitz, M.D., Markus Loeffler, M.D.
Journal: Blood
Blood (2006) 108 (11): 205.
https://doi.org/10.1182/blood.V108.11.205.205
Published: 2006
Journal Articles

Outcome of Patients with Primary Mediastinal Large B-Cell Non-Hodgkin’s Lymphomas: A Single Institution Analysis from 1996-2004.

Ute Hegenbart, M.D., Michael Rieger, M.D., Matthias Witzens, M.D., Manfred Hensel, M.D., Anthony D. Ho, M.D.
Journal: Blood
Blood (2004) 104 (11): 3302.
https://doi.org/10.1182/blood.V104.11.3302.3302
Published: 2004